NCT06220968

Brief Summary

The study aimed at evaluating the impact of glycemic control on the erectile function , penile Doppler, and cavernosal blood NO and glutathione levels among a group of diabetic patients with erectile dysfunction.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 24, 2024

Completed
11 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

Same day

First QC Date

December 19, 2023

Last Update Submit

September 4, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Penile doppler ultrasound

    penile Doppler and measuring cavernosal blood nitric oxide and glutathione levels to compare penile doppler ultrasound brfore and after glycemic control .

    Baseline

  • Cavernosal blood nitric oxide

    Comparing cavernosal blood nitric oxide brfore and after glycemic control

    Baseline

  • Cavernosal blood glutathione level

    Comparing cavernosal blood glutathione levels brfore and after glycemic control

    Baseline

Eligibility Criteria

Age30 Years - 55 Years
Sexmale
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This prospective observational study will include 100 patients attending our andrology outpatient clinic at Assuit University Hospitals, Egypt, complaining of uncontrolled diabetes mellitus (HBA1C more than 8) and secondary ED for more than 6 months, from October 2023 and over a year. Patients will be included in the study after obtaining a written informed consent and ethical committee approval.

You may qualify if:

  • Married Male patients diagnosed with erectile dysfunction.
  • Age from 30 to 55 years.
  • Documented history of DM.
  • Regular sexual life with cooperative wife.

You may not qualify if:

  • Patients with congenital anomalies like hypospadius and curvature.
  • History of pelvic or spine surgery.
  • Single patient.
  • Thyroid disorders.
  • Other sexual disorders.
  • Primary ED.
  • History of Peyronie's disease or priapism.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Ahmed Ab Elshibany

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident

Study Record Dates

First Submitted

December 19, 2023

First Posted

January 24, 2024

Study Start

January 1, 2025

Primary Completion

January 1, 2025

Study Completion

March 1, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09